Article Details

Japan Approves Evrysdi as First At-home, Oral SMA Treatment

Retrieved on: 2021-06-25 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Japan Approves Evrysdi as First At-home, Oral SMA Treatment. View article details on hiswai:

Excerpt

Evrysdi is developed by Roche and its subsidiary Genentech, in collaboration with PTC Therapeutics and the SMA Foundation. The approval was based ...

Article found on: smanewstoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up